Cerence (CRNC) Tops Q4 EPS by 8c

Cerence (NASDAQ: CRNC) reported Q4 EPS of ($0.14), $0.08 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $58.1 million versus the consensus estimate of $56.09 million.

GUIDANCE:

First quarter and full fiscal 2023 guidance will be provided during the investor day presentation.

For earnings history and earnings-related data on Cerence (CRNC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance